Clinical Trial Update: A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effectiveness of tirzepatide after initiating ixekizumab in adults with moderate-to-severe plaque psoriasis and overweight…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Plaque Psoriasis

Drugs mentioned

• Ixekizumab (ixekizumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriasis, Overweight or Obesity | Phase 4 | Status: RECRUITING